Hikal Ltd.

View in App
295.85 +2.35 ▲0.8%

29 September 2023, 04:01:00 PM
Volume: 20,346

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hikal.com
Market Cap 3,649.09 Cr.
Enterprise Value(EV) 4,337.49 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 7.64 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 38.74 Trailing Twelve Months Ending 2023-06
Industry PE 38.47 Trailing Twelve Months Ending 2023-06
Book Value / Share 92.49 Trailing Twelve Months Ending 2023-06
Price to Book Value 3.20 Calculated using Price: 295.85
Dividend Yield 0.41 Period Ending 2023-03
No. of Shares Subscribed 12.33 Cr. 123,300,750 Shares
FaceValue 2
About Hikal Ltd.
Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA.

Hikal Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Hikal Ltd. Performance

View details >>
1 Day
+0.80%
1 Week
-2.25%
1 Month
+3.70%
3 Month
-5.18%
6 Month
+9.92%
1 Year
-9.21%
2 Year
-51.22%
5 Year
+84.73%
10 Year
+409.82%

Hikal Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 9.81 9.32 12.74 12.12 14.46 10.74 15.22 16.04 7.12
Return on Capital Employed (%) 12.50 11.92 11.87 12.81 15.25 12.44 16.15 15.21 8.47
Return on Assets (%) 3.12 3.17 5.02 5.15 6.11 4.62 6.84 7.39 3.27

Hikal Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 505 532 564 605 669 756 817 933 1,068 1,133
Non Curr. Liab. 298 242 337 324 312 359 410 379 432 646
Curr. Liab. 479 530 397 470 616 659 653 703 828 691
Minority Int.
Equity & Liab. 1,282 1,304 1,298 1,400 1,597 1,775 1,879 2,016 2,328 2,471
Non Curr. Assets 775 791 808 793 851 888 1,048 1,091 1,305 1,502
Curr. Assets 507 513 490 607 746 886 831 925 1,023 968
Misc. Exp. not W/O
Total Assets 1,282 1,304 1,298 1,400 1,597 1,775 1,879 2,016 2,328 2,471

Hikal Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 872 926 1,014 1,296 1,590 1,507 1,720 1,943 2,023 2,032
Other Income 2 2 3 4 2 4 5 5 5 5
Total Income 873 927 1,017 1,301 1,592 1,511 1,725 1,948 2,028 2,037
Total Expenditure -689 -745 -815 -1,054 -1,291 -1,234 -1,398 -1,602 -1,766 -1,750
PBIDT 184 183 202 246 300 277 328 345 262 288
Interest -60 -62 -48 -49 -58 -52 -36 -31 -48 -51
Depreciation -64 -67 -69 -86 -93 -82 -85 -96 -109 -110
Taxation -19 -12 -13 -34 -46 -42 -73 -58 -27 -33
Exceptional Items -4 -15
PAT 40 41 68 77 103 84 133 161 78 94
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 40 41 68 77 103 84 133 161 78 94
Adjusted EPS 3 3 5 6 8 7 11 13 6 8

Hikal Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 154 102 186 163 139 186 285 229 294 315
Cash Fr. Inv. -23 -43 -64 -102 -110 -125 -164 -156 -284 -292
Cash Fr. Finan. -124 -69 -124 -63 -25 -55 -101 -97 -6 -8
Net Change 7 -10 -2 -2 4 6 20 -24 4 15
Cash & Cash Eqvt 16 6 4 2 6 11 32 8 11 27

Hikal Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 68.77 68.77 68.77 68.77 68.77 68.77 68.83 68.85 68.85
Public 31.23 31.23 31.23 31.23 31.23 31.23 31.17 31.15 31.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Hikal Ltd. Announcements

View details >>
Fri, 29 Sep 2023
Closure of Trading Window
Intimation of closure of trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015
Wed, 27 Sep 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release titled "appointment of Independent Directors"
Tue, 26 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizers Report on E-voting conducted for the 35th Annual General Meeting of the Company held on September 26 2023

Hikal Ltd. Technical Scans

View details >>
Fri, 29 Sep 2023
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days

Hikal Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 278,106.92 1,159.10 +2.4%
Divi's Laboratories Ltd. 99,942.28 3,761.95 +2.7%
Cipla Ltd. 95,813.38 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. 93,178.48 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. 73,867.93 5,149.95 +2.5%
Mankind Pharma Ltd. 71,831.52 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. 65,264.13 1,928.35 +3.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.97 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.60 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 30.87 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.76 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.76 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 56.04 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 51.80 1,928.35 +3.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.79 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.61 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 3.95 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.80 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.81 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.87 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.92 1,928.35 +3.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,928.35 +3.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,928.35 +3.4%

Hikal Ltd. FAQ's

What is Hikal share price?
Can I buy Hikal shares now?
What is the Dividend Yield of Hikal?
What is the Market Cap of Hikal?
What are the key metrics to analyse Hikal?
What is the 52 Week High and Low of Hikal?
What is the trend of Hikal share price?